Management of Esophagogastric Junction Cancer
DOI:
https://doi.org/10.59928/bqbn8733Keywords:
esophagogastric junction cancer, definition, management, multimodal approach, surgical treatmentAbstract
The management of Esophagogastric Junction (EGJ) cancer remains a complex issue due to the difficulty in defining it clearly. For this reason, the 8 th edition of the TNM classification, defines EGJ adenocarcinoma as the cancer with epicenter located within 2cm proximal or distal to the EGJ which is now considered as esophageal cancer. The diagnosis of EGJ adenocarcinoma is achieved by endoscopy and biopsy while CT, endoscopic ultrasound, PET CT and laparoscopy are essential for the accurate staging of the disease. Treatment of EGJ adenocarcinoma requires a multimodal approach through which the combination of surgery, chemotherapy, immunotherapy and radiotherapy will offer the pa tient the best possible choice. As surgery remains the cornerstone of curative treatment, the optimal surgical approach (transthoracic or transhiatal surgery) and the extent of lymphadenectomy play critical role in both pa tient morbidity and overall survival. This review deals with the current practices in the management of EGJ cancer from diagnosis to definitive treatment.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.